These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28386671)

  • 21. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
    Dickson DW; Farlo J; Davies P; Crystal H; Fuld P; Yen SH
    Am J Pathol; 1988 Jul; 132(1):86-101. PubMed ID: 2456021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):109-20. PubMed ID: 22582881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
    Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
    Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
    J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuritic plaque in Alzheimer's disease: perivascular degeneration of neuronal processes.
    Hansra GK; Popov G; Banaczek PO; Vogiatzis M; Jegathees T; Goldsbury CS; Cullen KM
    Neurobiol Aging; 2019 Oct; 82():88-101. PubMed ID: 31437721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques.
    Joachim C; Games D; Morris J; Ward P; Frenkel D; Selkoe D
    Am J Pathol; 1991 Feb; 138(2):373-84. PubMed ID: 1704190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease.
    Serrano-Pozo A; Muzikansky A; Gómez-Isla T; Growdon JH; Betensky RA; Frosch MP; Hyman BT
    J Neuropathol Exp Neurol; 2013 Jun; 72(6):462-71. PubMed ID: 23656989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
    Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.
    Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM
    J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease.
    Vehmas AK; Kawas CH; Stewart WF; Troncoso JC
    Neurobiol Aging; 2003; 24(2):321-31. PubMed ID: 12498966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cofilin rods and aggregates concur with tau pathology and the development of Alzheimer's disease.
    Rahman T; Davies DS; Tannenberg RK; Fok S; Shepherd C; Dodd PR; Cullen KM; Goldsbury C
    J Alzheimers Dis; 2014; 42(4):1443-60. PubMed ID: 25024349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.
    Ahlemeyer B; Halupczok S; Rodenberg-Frank E; Valerius KP; Baumgart-Vogt E
    J Alzheimers Dis; 2018; 61(4):1425-1450. PubMed ID: 29376876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
    Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
    Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.
    Glabe C
    J Mol Neurosci; 2001 Oct; 17(2):137-45. PubMed ID: 11816787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.